Trials / Completed
CompletedNCT03179787
Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 528 (actual)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 6 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and effectiveness of aripiprazole in patients with autism in the real world clinical setting in Japan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aripiprazole oral product | oral administration of aripiprazole |
Timeline
- Start date
- 2017-04-01
- Primary completion
- 2020-03-17
- Completion
- 2020-07-06
- First posted
- 2017-06-07
- Last updated
- 2021-09-16
- Results posted
- 2021-09-16
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03179787. Inclusion in this directory is not an endorsement.